Amarin Corp Plc (AMRN)

[jfmcrr]

Ranjo - no -= its because Lovaza has been moved T4 requiring Prior Auth in many plans

While Vascepa is moved up to T2 / preferred in many plans smile

Don't fixate on Reduce It regarding growing scripts; Occam's razor. Rather than leaks in the data of an international double blind study somehow getting tabulated and distributed, how about a growing number of MD's putting together a track record of successful patient experiences in terms of #'s and feedback and using it on more patients in their own practice and talking about it to other MD's?

Less conspiracy, more what you'd expect and hope...